Please login to the form below

Not currently logged in
Email:
Password:

Oxford Pharmascience adds to board

John Goddard is former head of group strategic planning and business at AstraZeneca
John Goddard Oxford Pharmascience

Oxford Pharmascience has bulked up its board with the appointment of industry veteran John Goddard as independent non-executive director.

Goddard has years of experience in pharma including a spell as head of group strategic planning and business development at AstraZeneca until his retirement in 2010.

He joined AZ after his former company Zeneca merged with Astra in 1999.

Oxford Pharmascience's chair Dave Norwood commented that Goddard's experience in the industry would be valuable as the company initiates the commercialisation of its drug pipeline.

10th March 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics